Osteocalcin: Is it a useful marker of bone metastasis and response to treatment in advanced prostate cancer?
- 1 January 1992
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 20 (3), 169-177
- https://doi.org/10.1002/pros.2990200302
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Prognostic Significance of Prostate Specific Antigen in Endocrine Treatment for Prostatic CancerJournal of Urology, 1990
- Correlation between bone scans and serum levels of osteocalcin, prostate‐specific antigen, and prostatic acid phosphatase in monitoring patients with disseminated cancer of the prostateThe Prostate, 1989
- Osteocalcin: a potential marker of metastatic bone disease and response to treatmentEuropean Journal of Cancer and Clinical Oncology, 1988
- Heterogeneous Subpopulations of Human Prostatic Adenocarcinoma Cells: Potential Usefulness of P21 Protein as a Predictor for Bone MetastasisJournal of Urology, 1988
- Serum Osteocalcin Concentration in Patients with Prostatic CancerAmerican Journal of Clinical Oncology, 1988
- Transrectal ultrasonometry of the prostate: the prognostic relevance of volume changes under endocrine managementWorld Journal of Urology, 1986
- Biochemical Markers and Skeletal Metabolism in Carcinoma of the Prostate: Use of Decision Matrix Theory and ROC AnalysisBritish Journal of Urology, 1985
- New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.Journal of Clinical Investigation, 1980
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958